These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 99021)

  • 21. The effect of T3 and reverse T3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretion.
    Burman KD; Wartofsky L; Dinterman RE; Kesler P; Wannemacher RW
    Metabolism; 1979 Aug; 28(8):805-13. PubMed ID: 454518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Musle protein breakdown rates in humans based on Ntau-methylhistidine (3-methylhistidine) content of mixed proteins in skeletal muscle and urinary output of Ntau-methylhistidine.
    Bilmazes C; Uauy R; Haverberg LN; Munro HN; Young VR
    Metabolism; 1978 May; 27(5):525-30. PubMed ID: 642824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An automatic method for determination of urinary and myofibrillar 3-methylhistidine: fractional rate of myofibrillar protein breakdown in rats fed on casein as source of protein.
    Martínez JA; Larralde J
    Rev Esp Fisiol; 1984 Mar; 40(1):103-7. PubMed ID: 6463336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The short-term effects of protein intake on 3-methylhistidine excretion.
    Marliss EB; Wei CN; Dietrich LL
    Am J Clin Nutr; 1979 Aug; 32(8):1617-21. PubMed ID: 463800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of corticosterone and its route of administration on muscle protein breakdown, measured in vivo by urinary excretion of N tau-methylhistidine in rats: response to different levels of dietary protein and energy.
    Santidrian S; Moreyra M; Munro HN; Young VR
    Metabolism; 1981 Aug; 30(8):798-804. PubMed ID: 7266373
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of 3-methylhistidine in food on its urinary excretion in man.
    Elia M; Carter A; Bacon S; Smith R
    Clin Sci (Lond); 1980 Dec; 59(6):509-11. PubMed ID: 7438717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative determination of urinary N-tau-methylhistidine output as an index of myofibrillar protein degradation.
    Nagasawa T; Funabiki R
    J Biochem; 1981 Apr; 89(4):1155-61. PubMed ID: 6894750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown.
    Rennie MJ; Millward DJ
    Clin Sci (Lond); 1983 Sep; 65(3):217-25. PubMed ID: 6872456
    [No Abstract]   [Full Text] [Related]  

  • 29. Contribution of skeletal muscle protein in elevated rates of whole body protein catabolism in trauma patients.
    Long CL; Birkhahn RH; Geiger JW; Blakemore WS
    Am J Clin Nutr; 1981 Jun; 34(6):1087-93. PubMed ID: 7234737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dietary protein on urinary excretion of 3-methylhistidine in rat.
    Omstedt PT; Kihlberg R; Tingvall P; Shenkin A
    J Nutr; 1978 Dec; 108(12):1877-82. PubMed ID: 569190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous 3-methylhistidine excretion in healthy women and men with reference to muscle protein metabolism.
    Neuhäuser M; Bässler KH
    Z Ernahrungswiss; 1984 Sep; 23(3):171-80. PubMed ID: 6506809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myofibrillar protein degradation in the chicken. 3-Methylhistidine release in vivo and in vitro in normal and genetically muscular-dystrophic chickens.
    Hillgartner FB; Williams AS; Flanders JA; Morin D; Hansen RJ
    Biochem J; 1981 May; 196(2):591-601. PubMed ID: 7316997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of glucocorticoid-induced changes in myofibrillar protein turnover in rats by protein and energy deficiency as assessed by urinary excretion of Ntau-methylhistidine.
    Tomas FM; Murray AJ; Jones LM
    Br J Nutr; 1984 May; 51(3):323-37. PubMed ID: 6426502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
    Elia M; Carter A; Bacon S; Winearls CG; Smith R
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary excretion and efflux from the leg of 3-methylhistidine before and after major surgical operation.
    Rennie MJ; Bennegård K; Edén E; Emery PW; Lundholm K
    Metabolism; 1984 Mar; 33(3):250-6. PubMed ID: 6694565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary excretion of 3-methylhistidine in patients receiving parenteral nutrition.
    Kim CW; Okada A; Itakura T; Kawashima Y; Konishi H; Nakajima T
    JPEN J Parenter Enteral Nutr; 1979; 3(4):255-7. PubMed ID: 113594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of the fractional breakdown rates of myofibrillar proteins in chickens from quantitation of 3-methylhistidine excretion.
    Jones SJ; Aberle ED; Judge MD
    Poult Sci; 1986 Nov; 65(11):2142-7. PubMed ID: 3822994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myofibrillar protein degradation in premature infants with respiratory distress as assessed by 3-methylhistidine and creatinine excretions.
    Lunyong VE; Friedman Z
    Am J Clin Nutr; 1982 Sep; 36(3):485-91. PubMed ID: 7113954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Absence of effect of propranolol on urinary excretion of 3-methylhistidine in hyperthyroidism].
    Beylot M; Riou JP; Sautot G; Mornex R
    Presse Med; 1984 Sep 1-8; 13(30):1829-31. PubMed ID: 6236442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid status and muscle protein breakdown as assessed by urinary 3-methylhistidine excretion: study in thyrotoxic patients before and after treatment.
    Rodier M; Richard JL; Bringer J; Cavalié G; Bellet H; Mirouze J
    Metabolism; 1984 Jan; 33(1):97-100. PubMed ID: 6690888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.